[{"indications": "Indications\u00a0tuberculosis in combination with other drugs [unlicensed]", "name": "PYRAZINAMIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.1 Antibacterial drugs", "5.1.9 Antituberculosis drugs", "PYRAZINAMIDE"], "cautions": "Cautions\u00a0see Monitoring in notes above; also diabetes; gout (avoid in acute attack); interactions: Appendix 1\r\n(pyrazinamide)Hepatic disorders\u00a0Patients or their\r\ncarers should be told how to recognise signs of liver disorder, and\r\nadvised to discontinue treatment and seek immediate medical attention\r\nif symptoms such as persistent nausea, vomiting, malaise or jaundice\r\ndevelop", "side-effects": "Side-effects\u00a0hepatotoxicity including fever, anorexia, hepatomegaly,\r\nsplenomegaly, jaundice, liver failure; nausea, vomiting, flushing,\r\ndysuria, arthralgia, sideroblastic anaemia, thrombocytopenia, rash\r\nand occasionally photosensitivity", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3912.htm", "doses": ["See notes above"], "pregnancy": "Pregnancy\u00a0manufacturer advises use only if potential benefit\r\noutweighs risk; see also Pregnancy"}]